Initial Safety and Efficacy, Sequential Group, Adaptive Dose Study of GL-2045 Subcutaneous Injection Repeat Doses in Patients with Immune Thrombocytopenia GL-2045-03 (GL-2045-03)

Principal Investigator

Dr Sue Pavord

Contact us

Email: christopher.deane@ouh.nhs.uk

IRAS number

1013159